In recent years, the deodorant has risk factors of breast cancer. So far, no evidence has shown this assumption, but many women are worried. Today, experts from the French Cancer Society provide a reassuring answer.
The use of deodorants would affect the growth of breast cancer in women: no scientific study has demonstrated this possibility. A group of experts from the French Cancer Society, made a detailed and scientific analysis on this subject. Conclusion: No scientific evidence has been identified for this hypothesis.
Breast cancer: deodorants Charged
Several studies have noted a high incidence of breast cancer in the area close to the application of deodorants anti-transpiration (the upper outer quadrant) and use more and more common for these products.
Based on these findings, several research teams have sought to establish a possible link between anti-sweat and breast cancer. The most broadcasts retained the possible role of parabens and aluminum salts. However, to date, no epidemiological study has shown the assumption that the use of deodorants had an effect on increasing breast cancer in women.
No scientific evidence
A group of experts of the journal Cancer Bulletin, Official Organ of the French Cancer Society is a scientific analysis and detailed answer to the anguish of the women on this topic. They reviewed 59 studies from the literature search and 19 items of different methodology. Is their conclusion? No scientific evidence for the hypothesis could not be identified. Moreover, these experts explain that there are no validated hypothesis may open on avenues of research interest. They argue that this issue does not constitute a public health problem and it seems pointless to continue research on this topic. The AFSSAPS in 2006 had published information in the same direction. That is no reason for concern about using of a particular deodorant.
The importance of screening for breast cancer. What are the known risk factors for breast cancer? A minority of breast cancers related to a family who inherited form occurs most often at a young age, one of the major risk factors remaining estrogen. Thus, the prevention of this scourge based primarily on mammography screening cancer.
Breast cancer remains the most common cancer of women in Western countries: it affects one in nine women, mostly after menopause. It has caused 11 000 deaths in France in 2005. More breast cancer detected early; the greater the chances of recovery are important. Thanks to early detection, half of breast cancers detected when they are less than 2 cm. This level of detection can achieve very high cure rates while reducing the aggressiveness of treatment applied. You must regularly monitored by a doctor or a gynecologist who will prescribe the necessary examinations. particularly if it considers that you have family risk factors of breast cancer. This medical must be conducted every 6 months or every year from 30 years.
In France, the organized screening (every two years, a mammogram supported 100% by health insurance without advance fee) is available to women from 50 years and up to 74 years.